EVIO Canada's Keystone Labs Receives Health Canada Approval

 EVIO Inc., (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, is pleased to announce that it has received an approval from Health Canada on an amendment of its Dealer License that will expand the product and service offering for EVIO Canada's Keystone Labs in Edmonton effective August 24, 2018. 

EVIO Inc. Expands Footprint to Los Angeles to Meet Demand for July Cannabis Testing Rules

EVIO Inc. ("EVIO" or the "Company"), (OTCQB: EVIO), a leading North American provider of cannabis testing and scientific research for the regulated cannabis industry, announced today it has executed a long-term lease for a 2,700 square foot facility in Los Angeles, California to provide its accredited analytical testing services to the Southern California cannabis market.

EVIO Labs Is Positioned To Capitalize On The Increased Demand For Legal Cannabis

The cannabis sector has been under pressure and this pullback has created a great opportunity for cannabis investors. When you look back to the same time period last year, it looks likes cannabis stocks are following a similar trend and we are closely monitoring the recent weakness.

EVIO Labs Florida Licensee Announces ISO 17025 Accreditation

EVIO, Inc. (OTCQB:EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, announced today that its Florida Licensee, Kaycha Holdings LLC d/b/a EVIO Labs Florida has attained ISO 17025 accreditation and becomes the first accredited cannabis testing lab in the state.

Pages